TNF-α −308 G/A as a Risk Marker of Cervical Cancer Progression in the Polish Population

[21] Bashir MM(2013)A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer Tumour Biol. 34 1659-1556

[22] Sharma MR(2013)Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis PLoS One. 8 e69201-344

[23] Werth VP(2012)TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk Tumour Biol. 33 1549-244

[24] Baud V(2011)Characterization of single-nucleotide polymorphisms in the tumor necrosis factor α promoter region and in lymphotoxin α in squamous intraepithelial lesions, precursors of cervical cancer Transl Oncol. 4 336-153

[25] Karin M(2008)A pilot case-control association study of cytokine polymorphisms in Brazilian women presenting with HPV-related cervical lesions Eur J Obstet Gynecol Reprod Biol. 140 241-592

[26] Smyth MJ(2003)Polymorphism at the −308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer Int J Gynecol Cancer. 13 148-378

[27] Johnstone RW(2006)The allelic distribution of −308 tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women BMC Cancer. 6 24-2564

[28] Soto U(2005)G−308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer Biochem Biophys Res Commun. 334 588-1194

[29] Das BC(2014)TNF-α 308 G/A polymorphism and cervical intraepithelial neoplasia Anticancer Res. 34 373-256

[30] Lengert M(2014)Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer Tumour Biol. 35 2561-3114

[21] Bashir MM(2013)A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer Tumour Biol. 34 1659-1556

[22] Sharma MR(2013)Tumor necrosis factor alpha rs1800629 polymorphism and risk of cervical lesions: a meta-analysis PLoS One. 8 e69201-344

[23] Werth VP(2012)TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk Tumour Biol. 33 1549-244

[24] Baud V(2011)Characterization of single-nucleotide polymorphisms in the tumor necrosis factor α promoter region and in lymphotoxin α in squamous intraepithelial lesions, precursors of cervical cancer Transl Oncol. 4 336-153

[25] Karin M(2008)A pilot case-control association study of cytokine polymorphisms in Brazilian women presenting with HPV-related cervical lesions Eur J Obstet Gynecol Reprod Biol. 140 241-592

[26] Smyth MJ(2003)Polymorphism at the −308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer Int J Gynecol Cancer. 13 148-378

[27] Johnstone RW(2006)The allelic distribution of −308 tumor necrosis factor-alpha gene polymorphism in South African women with cervical cancer and control women BMC Cancer. 6 24-2564

[28] Soto U(2005)G−308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer Biochem Biophys Res Commun. 334 588-1194

[29] Das BC(2014)TNF-α 308 G/A polymorphism and cervical intraepithelial neoplasia Anticancer Res. 34 373-256

[30] Lengert M(2014)Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer Tumour Biol. 35 2561-3114